{"id":518787,"date":"2021-07-28T07:04:23","date_gmt":"2021-07-28T11:04:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\/"},"modified":"2021-07-28T07:04:23","modified_gmt":"2021-07-28T11:04:23","slug":"synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\/","title":{"rendered":"Synthetic Biologics to Report 2021 Second Quarter Operational Highlights and Financial Results on August 5, 2021"},"content":{"rendered":"
\n

Conference Call Scheduled for Thursday, August 5, 2021 at 4:30 p.m. ET<\/h2>\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n ROCKVILLE, Md.<\/span>, July 28, 2021<\/span> \/PRNewswire\/ —\u00a0Synthetic Biologics, Inc.<\/a> (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal (GI) diseases in areas of high unmet need, announced today that the Company intends to release its operational highlights and financial results for the quarter ended June 30, 2021<\/span> on Thursday, August 5, 2021<\/span>, and to host a conference call the same day at 4:30 p.m. ET<\/span>. The dial-in information for the call is as follows:<\/p>\n

\n

\n
\n \"Synthetic
\n <\/a>\n <\/p>\n<\/p><\/div>\n

U.S. (toll free): 1-888-347-5280
International: +1-412-902-4280 <\/p>\n

Participants are asked to dial in 15 minutes before the start of the call to register. The call will also be webcast over the Internet at https:\/\/www.webcaster4.com\/Webcast\/Page\/1096\/41790<\/a>. An archived replay of the call will be available for approximately ninety (90) days at the same URL, https:\/\/www.webcaster4.com\/Webcast\/Page\/1096\/41790<\/a> beginning approximately one hour after the call’s conclusion.<\/p>\n

\n About Synthetic Biologics, Inc.<\/b>\n <\/p>\n

Synthetic Biologics, Inc. (NYSE American: SYN) is a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal (GI) diseases in areas of high unmet need. The Company’s lead candidates are: (1) SYN-004 (ribaxamase) which is designed to degrade certain commonly used intravenous (IV) beta-lactam antibiotics within the gastrointestinal (GI) tract to prevent (a) microbiome damage, (b) Clostridioides<\/i>difficile<\/i> infection (CDI), (c) overgrowth of pathogenic organisms, (d) the emergence of antimicrobial resistance (AMR), and (e) acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant (HCT) recipients, and (2) SYN-020, a recombinant oral formulation of the enzyme intestinal alkaline phosphatase (IAP) produced under cGMP conditions and intended to treat both local GI and systemic diseases. For more information, please visit Synthetic Biologics’ website at www.syntheticbiologics.com<\/a>.\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021-301342530.html<\/a><\/p>\n

SOURCE Synthetic Biologics, Inc.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Conference Call Scheduled for Thursday, August 5, 2021 at 4:30 p.m. ET PR Newswire ROCKVILLE, Md., July 28, 2021 \/PRNewswire\/ —\u00a0Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal (GI) diseases in areas of high unmet need, announced today that the Company intends to release its operational highlights and financial results for the quarter ended June 30, 2021 on Thursday, August 5, 2021, and to host a conference call the same day at 4:30 p.m. ET. The dial-in information for the call is as follows: U.S. (toll free): 1-888-347-5280International: +1-412-902-4280 Participants are asked to dial in 15 minutes before the start of the call to register. The … <\/p>\n

Continue reading “Synthetic Biologics to Report 2021 Second Quarter Operational Highlights and Financial Results on August 5, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-518787","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSynthetic Biologics to Report 2021 Second Quarter Operational Highlights and Financial Results on August 5, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Synthetic Biologics to Report 2021 Second Quarter Operational Highlights and Financial Results on August 5, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Conference Call Scheduled for Thursday, August 5, 2021 at 4:30 p.m. ET PR Newswire ROCKVILLE, Md., July 28, 2021 \/PRNewswire\/ —\u00a0Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal (GI) diseases in areas of high unmet need, announced today that the Company intends to release its operational highlights and financial results for the quarter ended June 30, 2021 on Thursday, August 5, 2021, and to host a conference call the same day at 4:30 p.m. ET. The dial-in information for the call is as follows: U.S. (toll free): 1-888-347-5280International: +1-412-902-4280 Participants are asked to dial in 15 minutes before the start of the call to register. The … Continue reading "Synthetic Biologics to Report 2021 Second Quarter Operational Highlights and Financial Results on August 5, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-28T11:04:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/319502\/synthetic_biologics_inc_logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Synthetic Biologics to Report 2021 Second Quarter Operational Highlights and Financial Results on August 5, 2021\",\"datePublished\":\"2021-07-28T11:04:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\\\/\"},\"wordCount\":329,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/319502\\\/synthetic_biologics_inc_logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\\\/\",\"name\":\"Synthetic Biologics to Report 2021 Second Quarter Operational Highlights and Financial Results on August 5, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/319502\\\/synthetic_biologics_inc_logo.jpg\",\"datePublished\":\"2021-07-28T11:04:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/319502\\\/synthetic_biologics_inc_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/319502\\\/synthetic_biologics_inc_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Synthetic Biologics to Report 2021 Second Quarter Operational Highlights and Financial Results on August 5, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Synthetic Biologics to Report 2021 Second Quarter Operational Highlights and Financial Results on August 5, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\/","og_locale":"en_US","og_type":"article","og_title":"Synthetic Biologics to Report 2021 Second Quarter Operational Highlights and Financial Results on August 5, 2021 - Market Newsdesk","og_description":"Conference Call Scheduled for Thursday, August 5, 2021 at 4:30 p.m. ET PR Newswire ROCKVILLE, Md., July 28, 2021 \/PRNewswire\/ —\u00a0Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal (GI) diseases in areas of high unmet need, announced today that the Company intends to release its operational highlights and financial results for the quarter ended June 30, 2021 on Thursday, August 5, 2021, and to host a conference call the same day at 4:30 p.m. ET. The dial-in information for the call is as follows: U.S. (toll free): 1-888-347-5280International: +1-412-902-4280 Participants are asked to dial in 15 minutes before the start of the call to register. The … Continue reading \"Synthetic Biologics to Report 2021 Second Quarter Operational Highlights and Financial Results on August 5, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-28T11:04:23+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/319502\/synthetic_biologics_inc_logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Synthetic Biologics to Report 2021 Second Quarter Operational Highlights and Financial Results on August 5, 2021","datePublished":"2021-07-28T11:04:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\/"},"wordCount":329,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/319502\/synthetic_biologics_inc_logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\/","name":"Synthetic Biologics to Report 2021 Second Quarter Operational Highlights and Financial Results on August 5, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/319502\/synthetic_biologics_inc_logo.jpg","datePublished":"2021-07-28T11:04:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/319502\/synthetic_biologics_inc_logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/319502\/synthetic_biologics_inc_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/synthetic-biologics-to-report-2021-second-quarter-operational-highlights-and-financial-results-on-august-5-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Synthetic Biologics to Report 2021 Second Quarter Operational Highlights and Financial Results on August 5, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/518787","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=518787"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/518787\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=518787"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=518787"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=518787"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}